指南与共识生殖医学妇科

2025年WHO不孕不育指南男性生殖健康解读

Paternal reproductive health in focus: new World Health Organization infertility guideline interpreted through a biological and clinical lens.
指南 / 共识 · Reprod Biomed Online · 2026-02-23

本文从生殖生物学和转化男科学角度解读2025年WHO不孕不育指南中男性相关部分。指南要求对伴侣双方平行评估,男性评估围绕病史、聚焦体格检查和精液分析展开;治疗推荐保守,仅限临床精索静脉曲张修复和抗氧化治疗。指南将男性生殖健康纳入全球不孕不育策略,促进结构化评估、早期转诊和生殖公平。

要点

  • 指南要求对不孕不育伴侣双方进行平行评估
  • 男性评估以病史、聚焦体格检查和精液分析为分诊工具
  • 精液分析是描述性而非机制性检测,需深入研究精子染色质完整性等

核心结论

  • 2025年WHO指南首次将男性和女性不孕因素整合于统一公共卫生策略中。
  • 指南促进结构化评估、早期专科转诊和生殖公平,但强调机制理解的关键空白。

研究设计与样本

  • 本文为评论性文章,解读2025年WHO不孕不育指南中男性相关部分。

主要发现

  • 指南要求对伴侣双方平行评估,男性评估围绕病史、聚焦体格检查和精液分析展开。
  • 精液分析仍是描述性而非机制性检测,需深入研究精子染色质完整性、表观遗传学和分子功能。
  • 治疗推荐保守,仅限临床精索静脉曲张修复和抗氧化治疗,反映PICO优先排序、GRADE方法学及对妊娠和活产结局的强调。

关键数值与推荐

  • 指南推荐对伴侣双方平行评估。
  • 男性评估包括病史、聚焦体格检查和精液分析作为分诊工具。
  • 治疗推荐仅限临床精索静脉曲张修复和抗氧化治疗。

临床怎么用

  • 临床应遵循指南对不孕不育伴侣双方进行平行评估。
  • 男性评估应包含病史、聚焦体格检查和精液分析。
  • 治疗决策应基于指南推荐,限于临床精索静脉曲张修复和抗氧化治疗。

局限性

  • 精液分析作为描述性检测,无法揭示精子染色质完整性、表观遗传学和分子功能等机制。
  • 指南治疗推荐保守,反映证据优先级和方法学限制,可能未涵盖所有潜在干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 2025 World Health Organization (WHO) Guideline for the Prevention, Diagnosis, and Treatment of Infertility represents the first comprehensive global framework integrating male and female contributors to infertility within a unified public health strategy. This commentary examines the male-relevant components of the guideline from the perspective of reproductive biology and translational andrology. The WHO guideline mandates a parallel evaluation of both partners and structures male assessment around the medical history, a focused physical examination and semen analysis as a triage tool. While pragmatic and globally applicable, semen analysis remains a descriptive rather than a mechanistic test, underscoring the need for a deeper investigation into sperm chromatin integrity, epigenetics and molecular function. The guideline's conservative treatment recommendations - limited to clinical varicocele repair and antioxidant therapy - reflect Population, Intervention, Comparison, Outcome prioritization, the GRADE methodology and an emphasis on pregnancy and live-birth outcomes, as well as considerations of equity and feasibility across diverse health systems. By embedding male reproductive health within a global infertility approach, the guideline promotes structured evaluation, early specialist referral and reproductive equity, while highlighting critical gaps in mechanistic understanding that must inform future research and clinical innovation.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Esteves SC, Pacey A, De Jonge CJ, et al. Paternal reproductive health in focus: new World Health Organization infertility guideline interpreted through a biological and clinical lens. Reprod Biomed Online. 2026. PMID: 41985248. doi:10.1016/j.rbmo.2026.105658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。